Abstract
The HAS recommends using the mRNA vaccines currently available (COMIRNATY or Covid-19 Moderna vaccine) for the administration (with the individual's agreement) of the second dose in people under 55 years of age who have received a first dose of the AstraZeneca vaccine (newly called VAXZEVRIA vaccine), with an interval of 12 weeks between doses.
Recommendation
Europe
France
AstraZeneca COVID-19 vaccine
COVID-19
